Loading company…
Xingzhi Bio develops liquid biopsy technologies, molecular biology reagents, and automated nucleic acid extraction products.
Xingzhi Bio develops liquid biopsy technologies, primers and probes, molecular biology reagents, and automated nucleic acid extractors. Its products support DNA and RNA extraction from biological samples for clinical testing, research, genomics, food safety, and other applications. Founded in 2019 and based in Suzhou, China, the company has an R&D center in Suzhou and a medical device production workshop in Hefei.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in